UK markets open in 1 hour 26 minutes

RNA Jan 2025 35.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.20000.0000 (0.00%)
As of 12:44PM EDT. Market open.
Full screen
Previous close4.2000
Open4.2000
Bid0.0000
Ask0.0000
Strike35.00
Expiry date2025-01-17
Day's range4.2000 - 4.2000
Contract rangeN/A
Volume35
Open interestN/A
  • PR Newswire

    Avidity Biosciences to Participate in Upcoming Investor Conference

    Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will be participating at the following upcoming conference:

  • PR Newswire

    Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock

    Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the pricing of an underwritten public offering of 10,550,000 shares of its common stock at a price to the public of $38.00 per share. All of the shares to be sold in the offering are to be sold by Avidity. The gross proceeds to Avidity from the offering, before deducting the underwriting discounts and comm

  • Zacks

    Avidity (RNA) Up 33% on Rare Muscle Disease Study Results

    Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.